PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBRoche’s Genentech acquires Regor Pharmaceuticals’ CDK inhibitors for $850m upfront. Novo Nordisk and NanoVation to develop genetic medicines in partnership worth $600m. Sanofi, RadioMedix and Orano Med partner to develop rare cancer therapy in deal worth €320m. Gilead and AI-focused Genesis partner to develop small molecule therapies.
Pfizer and BioNTech share late-stage results for COVID-19/flu ...
WEBAug 16, 2024 · Pfizer and BioNTech have announced top-line results from a late-stage study of their mRNA-based combination vaccine for influenza and COVID-19. The partners have been evaluating the candidate against a licensed flu vaccine and their own licensed COVID-19 vaccine given at the same visit in more …
Expert review shows AstraZeneca’s COVID-19 vaccine is ‘equally ...
WEBJul 13, 2022 · The study informs policymakers about the optimal deployment of COVID-19 vaccines over the next 12 months. AstraZeneca’s (AZ) COVID-19 vaccine, Vaxzevria, and the available mRNA COVID-19 vaccines provide ‘equally effective’ protection against hospitalisation and death, an expert review of data from 79 real-world studies has revealed.
Moderna’s COVID-19/flu combination vaccine shows promise in
WEBOct 5, 2023 · Moderna has announced positive results from a phase 1/2 trial of its investigational mRNA combination vaccine against influenza and COVID-19. The combined vaccine approach has the potential to alleviate the impact of both flu and COVID-19 while offering a combined administration, potentially simplifying immunisation practices and leading to higher vaccine uptake.
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, …
WEBOptimizing Patient Recruitment & Retention in Influenza Studies. With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase.
Sales - PMLiVE
WEBEli Lilly and Genetic Leap partner to develop RNA-targeted therapies in deal worth $409m. Sep 10, 2024 | News, Sales. The companies will use Genetic Leap’s AI platform to generate oligonucleotide drugs against targets selected by Lilly. Read More.
Research - PMLiVE
WEBFeb 23, 2024 · Bristol Myers Squibb announces positive data for Sotyktu in moderate-to-severe psoriasis. Oct 2, 2024 | News, Research. At least 100 million people worldwide are affected by the immune-mediated disease. Read More.
PME - PMLiVE
WEBPharmaceutical Market Europe – October 2023. Launch excellence – adapting to data disruption; preparing for the clinical trials of the future; the impact of cell therapies on cancer treatments.
The handover: Pfizer reshapes itself for a new era - PMLiVE
WEBNov 8, 2018 · Pfizer has just reported Q3 sales up 1% to $13.3bn, slightly below analysts’ forecasts, but still on course for a solid performance in 2018. Innovative health revenue increased 4% to $8.47bn, lifted by sales of blood thinner Eliquis and breast cancer drug Ibrance outside the US, among others. Pfizer’s chief financial officer and executive ...
Researchers improve understanding of COVID-19 virus and future …
WEBNov 9, 2023 · Researchers from the UK Research and Innovation’s (UKRI) Science and Technology Facilities Council’s (STFC) Hartree Centre and IBM have provided valuable insights to understand the SARS-CoV-2 virus and its future variants.